PRO-DEX, INC. Available-for-sale Securities, Amortized Cost Basis
PRO-DEX, INC. (PDEX) had Available-for-sale Securities, Amortized Cost Basis of $2.71 million as of 2022-12-31, per its 10-Q filed 2023-02-02.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2023-02-02
- 2022-12-31: Available-for-sale Securities, Amortized Cost Basis $2.71M.
- 2022-09-30: Available-for-sale Securities, Amortized Cost Basis $2.71M.
- 2022-06-30: Available-for-sale Securities, Amortized Cost Basis $2.80M.
- 2022-03-31: Available-for-sale Securities, Amortized Cost Basis $3.54M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2022-12-31 | $2.71M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $2.71M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $2.80M 10-Q · filed 2023-02-02 |
| 2022-03-31 | $3.54M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $3.54M 10-Q · filed 2022-02-03 |
| 2021-09-30 | $3.22M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.20M 10-K · filed 2022-09-08 |
| 2021-03-31 | $4.27M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $6.38M 10-Q · filed 2021-02-04 |
| 2020-09-30 | $6.38M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $6.48M 10-K · filed 2021-09-09 |
| 2020-03-31 | $5.59M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $5.05M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $5.04M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $3.78M 10-K · filed 2020-09-10 |
| 2019-03-31 | $3.36M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $2.19M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $3.20M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $2.37M 10-K · filed 2019-09-12 |
| 2018-03-31 | $1.47M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $961.00K 10-Q · filed 2018-02-08 |
| 2017-09-30 | $961.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $663.00K 10-K · filed 2018-09-13 |
| 2017-03-31 | $336.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $300.00K 10-Q · filed 2017-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |